Alprenoxime
Alprenoxime is a beta blocker.[1] It is a prodrug to alprenolol.[1]
| Molecular Weight | 262.34738 g/mol |
| Molecular Formula | C15H22N2O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 262.168128 g/mol |
| Monoisotopic Mass | 262.168128 g/mol |
| Topological Polar Surface Area | 53.8 A^2 |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 290 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
![]() | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C15H22N2O2 |
| Molar mass | 262.35 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
References
- Prokai L, Wu WM, Somogyi G, Bodor N (May 1995). "Ocular delivery of the beta-adrenergic antagonist alprenolol by sequential bioactivation of its methoxime analogue". Journal of Medicinal Chemistry. 38 (11): 2018–20. doi:10.1021/jm00011a021. PMID 7783133.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
